Pain-acceptance training for adults with chronic somatic pain and emotional distress

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Persistent somatic symptoms such as chronic pain are common and often respond poorly to conventional psychotherapies. This interventional study delivers a pain-acceptance training grounded in dialectical behavior therapy principles, teaching participants to both acknowledge the wish to end pain and cultivate acceptance of pain as it is. Adults aged 18–70 who report significant pain that interferes with daily functioning and elevated emotional distress will receive the intervention and be followed for changes in somatic pain and functioning. The study will also measure dialectical thinking to test whether increases in this cognitive style mediate any treatment effects.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Men and Women
2. Aged 18-70
3. Able to provide a signed informed consent
4. Experiencing significant pain symptoms that interfere with daily-life functioning
5. Experiencing significant emotional distress symptoms

Exclusion Criteria:

Patients under the age of 18 and/or diagnosed with one or more of the following diagnoses will be excluded from participation in the study:

1. Patients rating their average pain in the last week and in the last month as less than 3 in a 0-10 numerical rating scale (i.e. NPS)
2. Patients rating their emotional distress levels as less than 25 in a 10-50 numerical rating scale (i.e. Kessler Psychological Distress Scale \[K10\])
3. Patients diagnosed with psychotic disorders and/or suffering from psychotic symptoms.
4. Patients diagnosed with Autism Spectrum disorder.
5. Patients diagnosed with Intellectual disability.
6. Patients diagnosed with eating disorders.
7. Patients with Immediate suicidal risk.
8. Patients who initiated a new drug and/or psychotherapy treatment within the last month.
9. Pregnant women.
10. Patients currently serving in the IDF.

Where it's running

• Psychiatric Division, Rambam Health Care Campus
  Haifa, Israel Recruiting
• University of Haifa
  Haifa, Israel Recruiting

Study contacts

• Study coordinator: Sulamit Grinapol
• Email: s_grinapol@rambam.health.gov.il
• Phone: +972 047771718

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Cognitive Rehabilitation of Everyday Goals With GMT: How Different Ways of Delivery Work

  This study tests Goal Management Training to see if a Swedish version helps adults with acquired brain injury or chronic pain improve practical goal-directed thinking and daily functioning.

  Recruiting at 2 sites Karolinska Institutet · Luleå, Norrbotten County and 2 other locations · NCT07924774

• One-time Pain Reprocessing Therapy session for chronic pain at The Ottawa Hospital

  A single four-hour session of Pain Reprocessing Therapy is being tested to see if it can help adults with chronic pain feel better and have less pain.

  Recruiting Ottawa Hospital Research Institute · Ottawa, Ontario · NCT07919626

• Meaning-Based Psychotherapy for Adults with Chronic Pain

  This trial tests whether Meaning-Based Psychotherapy helps adults with chronic pain feel more purposeful, feel less depressed, and have a better quality of life compared with optimized usual care therapy.

  Recruiting Hospital Clinico Universitario San Cecilio · Granada, Granada · NCT07915440

• How chronic pain changes over time in kids with Duchenne Muscular Dystrophy

  This study is following children and teens with Duchenne Muscular Dystrophy for 6 months to see how their chronic pain changes and how it affects daily life.

  Recruiting Antalya Training and Research Hospital · Antalya, Antalya · NCT07892196

• CBD for Opioid Dependence and Pain on Buprenorphine

  This study tests whether different doses of cannabidiol (CBD) can affect pain and opioid cravings in adults with opioid use disorder who are on buprenorphine, using a short, randomized, placebo-controlled setup.

  Recruiting Early Phase 1 Yale University · West Haven, Connecticut · NCT07886606

• Cebranopadol for opioid withdrawal in adults with chronic pain

  This study tests whether cebranopadol can reduce withdrawal symptoms in adults with chronic pain who are physically dependent on prescribed opioids, compared with placebo.

  Recruiting at 2 sites Phase 2 Adneuris Therapeutics, Inc. · North Canton, Ohio and 1 other locations · NCT07874620

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.